| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Comprehensive Drug Screen, Umbilical Cord Tissue
Test Code94488
CPT Codes
80307
Includes
6-Monoacetylmorphine Free, 7-Amino Clonazepam, Acetyl Fentanyl, alpha-PVP, Alprazolam, Amphetamine, Benzoylecgonine, Buprenorphine Free, Butalbital, Carisoprodol, Chlordiazepoxide, Clonazepam, Cocaethylene, Cocaine, Codeine Free, Delta-9 Carboxy THC, Delta-9 THC, Desalkylflurazepam, Dextro/Levo Methorphan, Diazepam, Dihydrocodeine/Hydrocodol Free, EDDP, Ethylone, Fentanyl, Flunitrazepam, Flurazepam, Gabapentin, Hydrocodone Free, Hydromorphone Free, Hydroxytriazolam, Lorazepam, MDA, MDEA, MDMA, Meperidine, Meprobamate, Methadone, Methamphetamine, Methylone, Midazolam, Mitragynine, Morphine Free, Norbuprenorphine Free, Nordiazepam, Norfentanyl, Norhydrocodone, Normeperidine, Noroxycodone, O-Desmethyltramadol, Oxazepam, Oxycodone Free, Oxymorphone Free, Phencyclidine, Phenobarbital, Tapentadol, Temazepam, Tramadol, Triazolam, Zolpidem
If screening test is positive, confirmation test(s) will be added at no charge.
If screening test is positive, confirmation test(s) will be added at no charge.
Preferred Specimen
10 g umbilical cord
Minimum Volume
10 g
Instructions
Collect at least 6 inches of umbilical cord (approximately the length of an adult hand). Drain and discard any blood. Rinse the exterior of the cord segment with normal saline or sterile water. Pat the cord dry and place in container for transport. Store at refrigerated temperature.
Transport Container
Plastic container (preservative free)
Transport Temperature
Refrigerated (cold packs)
Specimen Stability
Room temperature: Undetermined
Refrigerated: 7 days
Frozen: 14 days
Refrigerated: 7 days
Frozen: 14 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Cords soaking in blood or other fluid • Formalin-fixed • Tissue that is obviously decomposed • Samples received without cold pack
Methodology
High Performance Liquid Chromatography/Tandem Mass Spectrometry (LC-MS/MS)
FDA Status
This test was developed and its performance characteristics have been determined by NMS Labs. It has not been cleared or approved by the US Food and Drug Administration.
Setup Schedule
As needed
Report Available
3-5 days
Reference Range
See Laboratory Report
Clinical Significance
Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology.
Performing Laboratory
| NMS Labs |
| 200 Welsh Road |
| Horsham, PA 19044 |
Last Updated: November 6, 2024
